Investigación / Grupos de investigación

Grupo  2

Biología Molecular del VIH

Publicaciones (394)

  • Chonco, L; Pion, M; Vacas, E; Rasines, B; Maly, M; Serramia, MJ; Lopez-Fernandez, L; De la Mata, J; Alvarez, S; Gomez, R; Munoz-Fernandez, MA.

    Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile

    JOURNAL OF CONTROLLED RELEASE. 2012; 161(3): 949-958 Nº de citas: 86 [doi:10.1016/j.jconrel.2012.04.050]

  • Garcia-Arriaza, J; Arnaez, P; Jimenez, JL; Gomez, CE; Munoz-Fernandez, MA; Esteban, M.

    Vector replication and expression of HIV-1 antigens by the HIV/AIDS vaccine candidate MVA-B is not affected by HIV-1 protease inhibitors

    VIRUS RESEARCH. 2012; 167(2): 391-396 Nº de citas: 3 [doi:10.1016/j.virusres.2012.05.020]

  • Gordon-Alonso, M; Sala-Valdes, M; Rocha-Perugini, V; Perez-Hernandez, D; Lopez-Martin, S; Ursa, A; Alvarez, S; Kolesnikova, TV; Vazquez, J; Sanchez-Madrid, F; Yanez-Mo, M.

    EWI-2 Association with alpha-Actinin Regulates T Cell Immune Synapses and HIV Viral Infection

    JOURNAL OF IMMUNOLOGY. 2012; 189(2): 689-700 Nº de citas: 49 [doi:10.4049/jimmunol.1103708]

  • Perise-Barrios, AJ; Munoz-Fernandez, MA; Pion, M.

    Direct Phenotypical and Functional Dysregulation of Primary Human B Cells by Human Immunodeficiency Virus (HIV) Type 1 In Vitro

    PLoS One. 2012; 7(7): Nº de citas: 13 [doi:10.1371/journal.pone.0039472]

  • Gonzalez-Serna, A; Romero-Sanchez, MC; Ferrando-Martinez, S; Genebat, M; Vidal, F; Munoz-Fernandez, MA; Abad, MA; Leal, M; Ruiz-Mateos, E.

    HIV-1 Tropism Evolution after Short-Term Maraviroc Monotherapy in HIV-1-Infected Patients

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2012; 56(7): 3981-3983 Nº de citas: 7 [doi:10.1128/AAC.00507-12]

  • Gordon-Alonso, M; Rocha-Perugini, V; Alvarez, S; Moreno-Gonzalo, O; Ursa, A; Lopez-Martin, S; Izquierdo-Useros, N; Martinez-Picado, J; Munoz-Fernandez, MA; Yanez-Mo, M; Sanchez-Madrid, F.

    The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry

    MOL BIOL CELL. 2012; 23(12): 2253-2263 Nº de citas: 35 [doi:10.1091/mbc.E11-12-1003]

  • Gras, R; Relloso, M; Garcia, MI; de la Mata, FJ; Gomez, R; Lopez-Fernandez, LA; Munoz-Fernandez, MA.

    The inhibition of Th17 immune response in vitro and in vivo by the carbosilane dendrimer 2G-NN16

    BIOMATERIALS. 2012; 33(15): 4002-4009 Nº de citas: 15 [doi:10.1016/j.biomaterials.2012.02.018]

  • Guzman-Fulgencio, M; Jimenez, JL; Berenguer, J; Fernandez-Rodriguez, A; Lopez, JC; Cosin, J; Miralles, P; Micheloud, D; Munoz-Fernandez, MA; Resino, S.

    Plasma IL-6 and IL-9 predict the failure of interferon-alpha plus ribavirin therapy in HIV/HCV-coinfected patients

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2012; 67(5): 1238-1245 Nº de citas: 29 [doi:10.1093/jac/dkr595]

  • Mendez-Lagares, G; Garcia-Perganeda, A; del Pozo-Balado, MD; Genebat, M; Ruiz-Mateos, E; Garcia, MG; Munoz-Fernandez, MA; Pacheco, YM; Leal, M.

    Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2012; 67(5): 1228-1237 Nº de citas: 29 [doi:10.1093/jac/dkr594]

  • Correa-Rocha, R; Perez, A; Lorente, R; Ferrando-Martinez, S; Leal, M; Gurbindo, D; Munoz-Fernandez, MA.

    Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7

    PEDIATRIC RESEARCH. 2012; 71(5): 590-597 Nº de citas: 73 [doi:10.1038/pr.2012.6]

  • Ferrando-Martinez, S; Casazza, JP; Leal, M; Machmach, K; Munoz-Fernandez, MA; Viciana, P; Koup, RA; Ruiz-Mateos, E.

    Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers

    JOURNAL OF VIROLOGY. 2012; 86(7): 3667-3674 Nº de citas: 55 [doi:10.1128/JVI.07034-11]

  • Yang, Y; Al-Mozaini, M; Buzon, MJ; Beamon, J; Ferrando-Martinez, S; Ruiz-Mateos, E; Rosenberg, ES; Pereyra, F; Yu, XG; Lichterfeld, M.

    CD4 T-cell regeneration in HIV-1 elite controllers

    AIDS. 2012; 26(6): 701-706 Nº de citas: 27 [doi:10.1097/QAD.0b013e3283519b22]

  • Gonzalez-Serna, A; McGovern, RA; Harrigan, PR; Vidal, F; Poon, AFY; Ferrando-Martinez, S; Abad, MA; Genebat, M; Leal, M; Ruiz-Mateos, E.

    Correlation of the Virological Response to Short-Term Maraviroc Monotherapy with Standard and Deep-Sequencing-Based Genotypic Tropism Prediction Methods

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2012; 56(3): 1202-1207 Nº de citas: 17 [doi:10.1128/AAC.05857-11]

  • Guillen, S; Prieto, L; de Ory, SJ; Gonzalez-Granado, I; Gonzalez-Tome, MI; Mellado, MJ; de Jose, M; Navarro, ML; Beceiro, J; Roa, MA; Munoz, MA; Ramos, JT.

    New diagnosis of HIV infection in children

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2012; 30(3): 131-136 Nº de citas: 5 [doi:10.1016/j.eimc.2011.09.007]

  • Briz, V; Leon-Leal, JA; Palladino, C; Moreno-Perez, D; de Ory, SJ; De Jose, MI; Gonzalez-Tome, MI; Martin, CG; Pocheville, I; Ramos, JT; Leal, M; Munoz-Fernandez, MA.

    Potent and Sustained Antiviral Response of Raltegravir-based Highly Active Antiretroviral Therapy in HIV Type 1-infected Children and Adolescents

    PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(3): 273-277 Nº de citas: 18 [doi:10.1097/INF.0b013e31824580e8]

  • Serrano-Villar, S; Estrada, V; Gomez-Garre, D; Avila, M; Fuentes-Ferrer, M; Sanchez-Parra, C; Sainz, T; Patino, R; Fernandez-Cruz, A.

    Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected Patients

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 59(2): 141-148 Nº de citas: 15 [doi:10.1097/QAI.0b013e3182414366]

  • Pedziwiatr-Werbicka, E; Shcharbin, D; Maly, J; Maly, M; Zaborski, M; Gabara, B; Ortega, P; de la Mate, FJ; Gomez, R; Munoz-Fernandez, MA; Klajnert, B; Bryszewska, M.

    Carbosilane Dendrimers are a Non-Viral Delivery System for Antisense Oligonucleotides: Characterization of Dendriplexes

    J BIOMED NANOTECHNOL. 2012; 8(1): 57-73 Nº de citas: 48 [doi:10.1166/jbn.2012.1369]

  • Weber, ND; Merkel, OM; Kissel, T; Munoz-Fernandez, MA.

    PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro

    JOURNAL OF CONTROLLED RELEASE. 2012; 157(1): 55-63 Nº de citas: 48 [doi:10.1016/j.jconrel.2011.09.059]